Alembic Pharmaceuticals Ltd
NSE:APLLTD
Wall Street
Price Targets
APLLTD Price Targets Summary
Alembic Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for
APLLTD
is 879.5 INR
with a low forecast of 535.3 INR and a high forecast of 1 200.15 INR.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Alembic Pharmaceuticals Ltd
For the last 8 years the
compound annual growth rate for
Alembic Pharmaceuticals Ltd's operating income is
3%.
The projected
CAGR
for the next 4 years is
32%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is APLLTD's stock price target?
Price Target
879.5
INR
According to Wall Street analysts, the average 1-year price target for
APLLTD
is 879.5 INR
with a low forecast of 535.3 INR and a high forecast of 1 200.15 INR.
What is Alembic Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
12%
For the last 8 years the
compound annual growth rate for
Alembic Pharmaceuticals Ltd's revenue is
13%.
The projected
CAGR
for the next 4 years is
12%.
What is Alembic Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
32%
For the last 8 years the
compound annual growth rate for
Alembic Pharmaceuticals Ltd's operating income is
3%.
The projected
CAGR
for the next 4 years is
32%.
What is Alembic Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
32%
For the last 8 years the
compound annual growth rate for
Alembic Pharmaceuticals Ltd's net income is
2%.
The projected
CAGR
for the next 4 years is
32%.
You don't have any saved screeners yet
